HOLLEY FOWLER: Open Payments
NPI 1063911790 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$356 in 23 payments from 7 companies in 2025. Trend: 2023 $27 · 2024 $470 · 2025 $356
Food & beverage: $356
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 12 | $137 |
| Lilly USA, LLC | 1 | $90 |
| Otsuka America Pharmaceutical, Inc. | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 2 | $30 |
| Kowa Pharmaceuticals America, Inc. | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 3 | $16 |
| Amgen Inc. | 1 | $15 |
Products named: CAPLYTA, ZEPBOUND, REXULTI, BREZTRI, ZORYVE, VOQUEZNA, OTEZLA.
Industry payments across AR — which companies pay providers there.
